(Q33279445)

25 July 2017

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy (English)

1 reference

25 July 2017

Vladimir Tolmachev

1

0 references

author name string

Anna Orlova

2

1 reference

25 July 2017

Fredrik Y Nilsson

3

1 reference

25 July 2017

Joachim Feldwisch

4

1 reference

25 July 2017

Anders Wennborg

5

1 reference

25 July 2017

Lars Abrahmsén

6

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

Expert Opinion on Biological Therapy

25 July 2017

1 reference

25 July 2017

7

1 reference

25 July 2017

555-568

1 reference

25 July 2017

4

1 reference

Targeted therapy of cancer: new prospects for antibodies and immunoconjugates

25 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Arming antibodies: prospects and challenges for immunoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Advances in radioimmunotherapy in the age of molecular engineering and pretargeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Molecular imaging in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Advantages of multi-color fluorescent proteins for whole-body and in vivo cellular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Molecular imaging in the development of cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Molecular imaging: an old and new field connecting basic science and clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Radiolabeled carbohydrated somatostatin analogs: a review of the current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Targeting peptides and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Radioimmunotherapy with engineered antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Pharmacokinetics and biodistribution of genetically engineered antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Receptor targeting for tumor localisation and therapy with radiopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Radiolabeled peptides in the diagnosis and therapy of oncological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Combinatorial discovery of tumor targeting peptides using phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Scaffolds for engineering novel binding sites in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Engineering novel bioactive mini-proteins from small size natural and de novo designed scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Binding proteins from alternative scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Engineering novel binding proteins from nonimmunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Artificial, non-antibody binding proteins for pharmaceutical and industrial applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

A new generation of protein display scaffolds for molecular recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

A combinatorial library of an alpha-helical bacterial receptor domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

A synthetic IgG-binding domain based on staphylococcal protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

All individual domains of staphylococcal protein A show Fab binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Making antibodies by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Selection and characterization of HER2/neu-binding affibody ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

An affibody in complex with a target protein: Structure and coupled folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Structural basis for recognition by an in vitro evolved affibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Tumor markers in breast cancer- European Group on Tumor Markers recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

HER2 therapy: molecular mechanisms of trastuzumab resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Evaluation of ((4-hydroxyphenyl)ethyl)maleimide for site-specific radiobromination of anti-HER2 affibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Epidermal growth factor receptor and bladder cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Panitumumab in colon cancer: a review and summary of ongoing trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Pharmacological background of EGFR targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Ligands selected from combinatorial libraries of protein A for use in affinity capture of apolipoprotein A-1M and taq DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

A novel affinity gene fusion system allowing protein A-based recovery of non-immunoglobulin gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Construction and characterization of affibody-Fc chimeras produced in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Dual labeling of a binding protein allows for specific fluorescence detection of native protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Fluorescent detection of beta-lactamase activity in living Escherichia coli cells via esterase supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Inhibition of the CD28-CD80 co-stimulation signal by a CD28-binding affibody ligand developed by combinatorial protein engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Selection and characterization of an HIV-1 gp120-binding affibody ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Efficient cancer therapy with a nanobody-based conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

Selection and characterization of Her2 binding-designed ankyrin repeat proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.4.555

21 January 2018

Identifiers

DOI

10.1517/14712598.7.4.555

1 reference

25 July 2017

1 reference